Net Income (TTM) Chart

View Net Income (TTM) for CMPX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -73.45M
March 31, 2026 -68.17M
December 31, 2025 -66.49M
September 30, 2025 -65.80M
June 30, 2025 -62.02M
March 31, 2025 -55.22M
December 31, 2024 -49.37M
September 30, 2024 -47.76M
June 30, 2024 -47.24M
March 31, 2024 -45.44M
December 31, 2023 -42.49M
September 30, 2023 -40.67M
June 30, 2023 -42.68M
March 31, 2023 -39.90M
Date Value
December 31, 2022 -39.22M
September 30, 2022 -40.61M
June 30, 2022 -34.61M
March 31, 2022 -81.92M
December 31, 2021 -82.18M
September 30, 2021 -77.59M
June 30, 2021 -80.77M
March 31, 2021 -30.52M
December 31, 2020 -29.50M
September 30, 2020 -27.72M
June 30, 2020 -27.12M
March 31, 2020 -30.38M
December 31, 2019 -34.74M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Viking Therapeutics, Inc. -534.80M
Capricor Therapeutics, Inc. -129.42M
Ardelyx, Inc. -55.70M
Biomea Fusion, Inc. -32.54M
ARS Pharmaceuticals, Inc. -215.43M